5Taggart C C, Greene C M, Carroll T P, et al. Elastolytic Proteas- es:inflammation resolution and dysregulation in cheonic infective lung disease[J].Am J Respir Crit Carr Med,2005,171:1070-1076.
4GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.
5Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.
6Celli BR,Cote CG,Marin JM,ct al.The body mass index,airflow obstruction,dyspnea and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012.
6Kunik M E, Veazey C, Cully J A, et al. COPD education and cog- nitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a random- ized controlled trial [ J ]. Psychological medicine, 2008, 38 (3) : 385.
